Search Results - "Wang, Michael W."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor by Nelson, Christopher A., Warren, Julia T., Wang, Michael W.-H., Teitelbaum, Steven L., Fremont, Daved H.

    Published in Structure (London) (07-11-2012)
    “…Osteoprotegerin (OPG) and receptor activator of nuclear factor κB (RANK) are members of the tumor necrosis factor receptor (TNFR) superfamily that regulate…”
    Get full text
    Journal Article
  2. 2

    Examining a punishment-related brain circuit with miniature fluorescence microscopes and deep learning by Broomer, Matthew C., Beacher, Nicholas J., Wang, Michael W., Lin, Da-Ting

    Published in Addiction neuroscience (01-06-2024)
    “…In humans experiencing substance use disorder (SUD), abstinence from drug use is often motivated by a desire to avoid some undesirable consequence of further…”
    Get full text
    Journal Article
  3. 3

    Minibox: Custom solo or semi-group housing chambers for long term housing of rats with miniscopes by Beacher, Nicholas J., Wang, Michael W., Broomer, Matthew C., Kuo, Jessica Y., Lin, Da-Ting

    Published in MethodsX (01-12-2024)
    “…In this detailed procedure, we include open-source methodologies using ‘solidworks’ designs for creating solo or semi-group housing units for rats wearing…”
    Get full text
    Journal Article
  4. 4

    The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling by Wang, Michael W-H, Wei, Shi, Faccio, Roberta, Takeshita, Sunao, Tebas, Pablo, Powderly, William G, Teitelbaum, Steven L, Ross, F Patrick

    Published in The Journal of clinical investigation (15-07-2004)
    “…Highly active antiretroviral therapy (HAART), which includes HIV protease inhibitors (PIs), has been associated with bone demineralization. To determine if…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling by Wei, Shi, Wang, Michael W.-H., Teitelbaum, Steven L., Ross, F. Patrick

    Published in The Journal of biological chemistry (22-02-2002)
    “…To define the molecular mechanism(s) by which interleukin (IL)-4 reversibly inhibits formation of osteoclasts (OCs) from bone marrow macrophages (BMMs), we…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors by Wei, Shi, Teitelbaum, Steven L., Wang, Michael W.-H., Ross, F. Patrick

    Published in Endocrinology (Philadelphia) (01-03-2001)
    “…Abstract Receptor activator of nuclear factor-κB ligand [RANK ligand (RANK-L)] stimulates mature osteoclasts to resorb bone, a process associated with NF-κB…”
    Get full text
    Journal Article
  9. 9

    The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling by Wang, Michael W.-H., Wei, Shi, Faccio, Roberta, Takeshita, Sunao, Tebas, Pablo, Powderly, William G., Teitelbaum, Steven L., Ross, F. Patrick

    Published in The Journal of clinical investigation (15-07-2004)
    “…Highly active antiretroviral therapy (HAART), which includes HIV protease inhibitors (PIs), has been associated with bone demineralization. To determine if…”
    Get full text
    Journal Article
  10. 10

    T Cell Repertoire Diversity Is Decreased in Type 1 Diabetes Patients by Yin Tong Zhoufang Li Hua Zhang Ligang Xia Meng Zhang Ying Xu Zhanhui Wang Michael W Deem Xiaojuan Sun Jiankui He

    “…Type 1 diabetes mellitus (T1D) is an immune-mediated disease. The autoreactive T cells in T1D patients attack and destroy their own pancreatic cells. In order…”
    Get full text
    Journal Article
  11. 11

    Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors1 by Wei, Shi, Teitelbaum, Steven L, Wang, Michael W.-H, Ross, F. Patrick

    Published in Endocrinology (Philadelphia) (01-03-2001)
    “…Receptor activator of nuclear factor-κB ligand [RANK ligand (RANK-L)] stimulates mature osteoclasts to resorb bone, a process associated with NF-κB activation…”
    Get full text
    Journal Article
  12. 12

    Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling by Shi Wei, Michael W.-H. Wang, Steven L. Teitelbaum, F. Patrick Ross

    Published in The Journal of biological chemistry (22-02-2002)
    “…To define the molecular mechanism(s) by which interleukin (IL)-4 reversibly inhibits formation of osteoclasts (OCs) from bone marrow macrophages (BMMs), we…”
    Get full text
    Journal Article